CTCL: Shortening the Diagnostic Journey and Starting Treatment Early
Yuliya Linhares, MD, Chief of Lymphoma Services at Miami Cancer Institute, discusses strategies for shortening the diagnostic journey of CTCL.
Yuliya Linhares, MD, Chief of Lymphoma Services at Miami Cancer Institute, discusses strategies for shortening the diagnostic journey of CTCL.
Nature Africa – Researchers shed light on the genes that could be linked to the high mortality rates of prostate cancer among men of African…
Updated results from the phase 3 CheckMate-8HW trial continue to show fewer severe (grade 3/4) side effects with nivolumab/ipilimumab compared to chemotherapy.
Three-year grant of $225,000 to support the salary and benefits of postdoctoral or clinical research fellows conducting lung cancer research.
The FDA has granted priority review to sunvozertinib for advanced/metastatic NSCLC with EGFR exon 20 insertion mutations after progression on chemotherapy.
Amivantamab plus lazertinib prolonged overall survival vs osimertinib as first-line therapy in locally advanced or metastatic, EGFR-mutant NSCLC.
At the San Antonio Breast Cancer Symposium, Komal Jhaveri, MD, FACP, presented results of the phase III EMBER-3 trial of imlunestrant, an oral selective estrogen…
The U.S. Preventive Services Task Force has endorsed allowing women 30 and older to collect their own samples to test for human papillomavirus
Long-lasting HPV infection causes almost all cervical cancers. Learn about HPV infection and other risk factors for cervical cancer and what you can do to…
Key PointsWe characterized erythropoiesis and iron metabolism in a new model of XLSA, showing ring sideroblasts and mitochondrial iron accumulation.We used
Authors of an article published in ONCOLOGY® detail how a novel multidisciplinary lifestyle medicine clinic can meet the needs of cancer survivors.